{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:47:38Z","timestamp":1790117258109,"version":"4.0.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus disease 2019 (COVID-19) pandemic has caused more than 6.3 million deaths to date. Despite great efforts to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines and neutralizing antibodies are in the gloom due to persistent viral mutations and antiviral compounds face challenges of specificity and safety. In addition, vaccines are unable to treat already-infected individuals, and antiviral drugs cannot be used prophylactically. Therefore, exploration of unconventional strategies to curb the current pandemic is highly urgent. Alveolar macrophages (AMs) residing on the surface of alveoli are the first immune cells that dispose of alveoli-invading viruses. Our findings demonstrate that M1 AMs have an acidic endosomal pH, thus favoring SARS-CoV-2 to leave endosomes and release into the cytosol where the virus initiates replication; in contrast, M2 AMs have an increased endosomal pH, which dampens the viral escape and facilitates delivery of the virus for lysosomal degradation. In this review, we propose that AMs are the Achilles\u2019 heel of SARS-CoV-2 infection and that modulation of the endosomal pH of AMs has the potential to eliminate invaded SARS-CoV-2; the same strategy might also be suitable for other lethal respiratory viruses.<\/jats:p>","DOI":"10.1038\/s41392-022-01106-8","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:07:36Z","timestamp":1658228856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Alveolar macrophages: Achilles\u2019 heel of SARS-CoV-2 infection"],"prefix":"10.1038","volume":"7","author":[{"given":"Zhenfeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunshun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-1138","authenticated-orcid":false,"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/S2214-109X(21)00464-2","volume":"10","author":"LAH Do","year":"2022","unstructured":"Do, L. A. H., Toh, Z. Q., Licciardi, P. V. & Mulholland, E. K. Can early measles vaccination control both measles and respiratory syncytial virus infections? Lancet Glob. Health 10, e288\u2013e292 (2022).","journal-title":"Lancet Glob. Health"},{"key":"1106_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pop.2013.06.004","volume":"40","author":"SN Grief","year":"2013","unstructured":"Grief, S. N. Upper respiratory infections. Prim. Care 40, 757\u2013770 (2013).","journal-title":"Prim. Care"},{"key":"1106_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","volume":"69","author":"SR Weiss","year":"2005","unstructured":"Weiss, S. R. & Navas-Martin, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69, 635\u2013664 (2005).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1106_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu, B., Guo, H., Zhou, P. & Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1106_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41423-020-00530-6","volume":"18","author":"J Varad\u00e9","year":"2021","unstructured":"Varad\u00e9, J., Magad\u00e1n, S. & Gonz\u00e1lez-Fern\u00e1ndez, \u00c1. Human immunology and immunotherapy: main achievements and challenges. Cell. Mol. Immunol. 18, 805\u2013828 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"1106_CR6","doi-asserted-by":"publisher","first-page":"751778","DOI":"10.3389\/fimmu.2021.751778","volume":"12","author":"D Tian","year":"2021","unstructured":"Tian, D., Sun, Y., Zhou, J. & Ye, Q. The global epidemic of the SARS-CoV-2 Delta variant, key spike mutations and immune escape. Front. Immunol. 12, 751778 (2021).","journal-title":"Front. Immunol."},{"key":"1106_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MCP.0000000000000153","volume":"21","author":"DS Hui","year":"2015","unstructured":"Hui, D. S. & Zumla, A. Emerging respiratory tract viral infections. Curr. Opin. Pulm. Med. 21, 284\u2013292 (2015).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"1106_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17460441.2019.1581171","volume":"14","author":"AL Totura","year":"2019","unstructured":"Totura, A. L. & Bavari, S. Broad-spectrum coronavirus antiviral drug discovery. Expert. Opin. Drug Disco. 14, 397\u2013412 (2019).","journal-title":"Expert. Opin. Drug Disco."},{"key":"1106_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","volume":"6","author":"A D\u00f6mling","year":"2020","unstructured":"D\u00f6mling, A. & Gao, L. Chemistry and Biology of SARS-CoV-2. Chem 6, 1283\u20131295 (2020).","journal-title":"Chem"},{"key":"1106_CR10","doi-asserted-by":"publisher","first-page":"104831","DOI":"10.1016\/j.micpath.2021.104831","volume":"154","author":"B Bakhshandeh","year":"2021","unstructured":"Bakhshandeh, B. et al. Mutations in SARS-CoV-2; consequences in structure, function, and pathogenicity of the virus. Microb. Pathog. 154, 104831 (2021).","journal-title":"Microb. Pathog."},{"key":"1106_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020). e278.","journal-title":"Cell"},{"key":"1106_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856\u2013860 (2020).","journal-title":"Science"},{"key":"1106_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41392-021-00845-4","volume":"6","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Escaping alveolar macrophage endosomal retention explains massive expansion of SARS-CoV-2 delta variant. Signal Transduct. Target. Ther. 6, 431 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/iub.2577","volume":"74","author":"M Ghosh","year":"2021","unstructured":"Ghosh, M., Basak, S. & Dutta, S. Underlying selection for the diversity of spike protein sequences of SARS-CoV-2. IUBMB Life 74, 213\u2013220 (2021).","journal-title":"IUBMB Life"},{"key":"1106_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-021-00258-1","volume":"7","author":"J Lv","year":"2021","unstructured":"Lv, J. et al. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages. Cell Discov. 7, 24 (2021).","journal-title":"Cell Discov."},{"key":"1106_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41423-021-00813-6","volume":"19","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages. Cell. Mol. Immunol. 19, 210\u2013221 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"1106_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.addr.2020.11.007","volume":"167","author":"D Sch\u00fctz","year":"2020","unstructured":"Sch\u00fctz, D. et al. Peptide and peptide-based inhibitors of SARS-CoV-2 entry. Adv. Drug. Deliv. Rev. 167, 47\u201365 (2020).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"1106_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019Kovski","year":"2021","unstructured":"V\u2019Kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19, 155\u2013170 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1106_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","volume":"198","author":"F Scialo","year":"2020","unstructured":"Scialo, F. et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung 198, 867\u2013877 (2020).","journal-title":"Lung"},{"key":"1106_CR20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183, 1043\u20131057 e1015 (2020).","journal-title":"Cell"},{"key":"1106_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.tibs.2021.06.001","volume":"46","author":"R Peng","year":"2021","unstructured":"Peng, R., Wu, L. A., Wang, Q., Qi, J. & Gao, G. F. Cell entry by SARS-CoV-2. Trends Biochem. Sci. 46, 848\u2013860 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"1106_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target. Ther. 5, 283 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41586-021-03925-1","volume":"598","author":"FA Lempp","year":"2021","unstructured":"Lempp, F. A. et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature 598, 342\u2013347 (2021).","journal-title":"Nature"},{"key":"1106_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 31, 126\u2013140 (2021).","journal-title":"Cell Res."},{"key":"1106_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41422-021-00595-6","volume":"32","author":"Y Gu","year":"2022","unstructured":"Gu, Y. et al. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res. 32, 24\u201337 (2022).","journal-title":"Cell Res."},{"key":"1106_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41392-022-01043-6","volume":"7","author":"X Li","year":"2022","unstructured":"Li, X., Zhang, Z., Wang, Z., Guti\u00e9rrez-Castrell\u00f3n, P. & Shi, H. Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19. Signal Transduct. Target Ther. 7, 186 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1106_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/glycob\/cwab032","volume":"31","author":"XL Sun","year":"2021","unstructured":"Sun, X. L. The role of cell surface sialic acids for SARS-CoV-2 infection. Glycobiology 31, 1245\u20131253 (2021).","journal-title":"Glycobiology"},{"key":"1106_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly, J. L. et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370, 861\u2013865 (2020).","journal-title":"Science"},{"key":"1106_CR29","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","volume":"2","author":"C Wei","year":"2020","unstructured":"Wei, C. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391\u20131400 (2020).","journal-title":"Nat. Metab."},{"key":"1106_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.abb9983","volume":"369","author":"Y Watanabe","year":"2020","unstructured":"Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science 369, 330\u2013333 (2020).","journal-title":"Science"},{"key":"1106_CR31","doi-asserted-by":"publisher","first-page":"e1009576","DOI":"10.1371\/journal.ppat.1009576","volume":"17","author":"M Thepaut","year":"2021","unstructured":"Thepaut, M. et al. DC\/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS Pathog. 17, e1009576 (2021).","journal-title":"PLoS Pathog."},{"key":"1106_CR32","doi-asserted-by":"publisher","first-page":"e12434","DOI":"10.7717\/peerj.12434","volume":"9","author":"B Khadka","year":"2021","unstructured":"Khadka, B. & Gupta, R. S. Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses. PeerJ 9, e12434 (2021).","journal-title":"PeerJ"},{"key":"1106_CR33","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/ijms23052558","volume":"23","author":"DE Scheim","year":"2022","unstructured":"Scheim, D. E. A deadly embrace: hemagglutination mediated by SARS-CoV-2 spike protein at its 22 N-glycosylation sites, red blood cell surface sialoglycoproteins, and antibody. Int. J. Mol. Sci. 23, 2558 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1106_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","volume":"15","author":"WH Man","year":"2017","unstructured":"Man, W. H., de Steenhuijsen Piters, W. A. A. & Bogaert, D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat. Rev. Microbiol. 15, 259\u2013270 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"1106_CR35","first-page":"283","volume":"51","author":"Y Tesfaigzi","year":"2003","unstructured":"Tesfaigzi, Y. Processes involved in the repair of injured airway epithelia. Arch. Immunol. Ther. Exp. 51, 283\u2013288 (2003).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"1106_CR36","first-page":"539","volume":"61","author":"EM McDowell","year":"1978","unstructured":"McDowell, E. M., Barrett, L. A., Glavin, F., Harris, C. C. & Trump, B. F. The respiratory epithelium. I. Human bronchus. J. Natl Cancer Inst. 61, 539\u2013549 (1978).","journal-title":"J. Natl Cancer Inst."},{"key":"1106_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1089\/jamp.2007.0659","volume":"21","author":"MA Mall","year":"2008","unstructured":"Mall, M. A. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J. Aerosol Med. Pulm. Drug Deliv. 21, 13\u201324 (2008).","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"1106_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.fsi.2018.02.006","volume":"75","author":"ST Tapia-Paniagua","year":"2018","unstructured":"Tapia-Paniagua, S. T., Ceballos-Francisco, D., Balebona, M. C., Esteban, M. \u00c1. & Mori\u00f1igo, M. \u00c1. Mucus glycosylation, immunity and bacterial microbiota associated to the skin of experimentally ulcered gilthead seabream (Sparus aurata). Fish. Shellfish Immunol. 75, 381\u2013390 (2018).","journal-title":"Fish. Shellfish Immunol."},{"key":"1106_CR39","doi-asserted-by":"publisher","first-page":"28146","DOI":"10.1007\/s11356-020-09156-7","volume":"27","author":"K \u010cabanov\u00e1","year":"2020","unstructured":"\u010cabanov\u00e1, K. et al. Metal particles in mucus and hypertrophic tissue of the inferior nasal turbinates from the human upper respiratory tract. Environ. Sci. Pollut. Res. Int. 27, 28146\u201328154 (2020).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"1106_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","volume":"532","author":"J Leal","year":"2017","unstructured":"Leal, J., Smyth, H. D. C. & Ghosh, D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int. J. Pharm. 532, 555\u2013572 (2017).","journal-title":"Int. J. Pharm."},{"key":"1106_CR41","doi-asserted-by":"publisher","first-page":"071001","DOI":"10.1115\/1.4004362","volume":"133","author":"S Chhabra","year":"2011","unstructured":"Chhabra, S. & Prasad, A. K. Flow and particle dispersion in lung acini: effect of geometric and dynamic parameters during synchronous ventilation. J. Fluids Eng. 133, 071001 (2011).","journal-title":"J. Fluids Eng."},{"key":"1106_CR42","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1021\/acsbiomaterials.1c00306","volume":"7","author":"M de Oliveira","year":"2021","unstructured":"de Oliveira, M., De Sibio, M. T., Costa, F. A. S. & Sakalem, M. E. Airway and alveoli organoids as valuable research tools in COVID-19. ACS Biomater. Sci. Eng. 7, 3487\u20133502 (2021).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"1106_CR43","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/ijms22052566","volume":"22","author":"B Ruaro","year":"2021","unstructured":"Ruaro, B. et al. The history and mystery of alveolar epithelial type II cells: focus on their physiologic and pathologic role in lung. Int. J. Mol. Sci. 22, 2566 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1106_CR44","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.biocel.2013.08.009","volume":"45","author":"L Guillot","year":"2013","unstructured":"Guillot, L. et al. Alveolar epithelial cells: master regulators of lung homeostasis. Int. J. Biochem. Cell Biol. 45, 2568\u20132573 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1106_CR45","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1152\/jappl.1992.73.3.941","volume":"73","author":"G Enhorning","year":"1992","unstructured":"Enhorning, G., Shumel, B., Keicher, L., Sokolowski, J. & Holm, B. A. Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble. J. Appl. Physiol. 73, 941\u2013945 (1992).","journal-title":"J. Appl. Physiol."},{"key":"1106_CR46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1165\/ajrcmb.24.3.4367","volume":"24","author":"SM Kreda","year":"2001","unstructured":"Kreda, S. M., Gynn, M. C., Fenstermacher, D. A., Boucher, R. C. & Gabriel, S. E. Expression and localization of epithelial aquaporins in the adult human lung. Am. J. Respir. Cell Mol. Biol. 24, 224\u2013234 (2001).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1106_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00424-018-2232-y","volume":"471","author":"OH Wittekindt","year":"2019","unstructured":"Wittekindt, O. H. & Dietl, P. Aquaporins in the lung. Pflug. Arch. 471, 519\u2013532 (2019).","journal-title":"Pflug. Arch."},{"key":"1106_CR48","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1183\/09031936.99.13614779","volume":"13","author":"M Griese","year":"1999","unstructured":"Griese, M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 13, 1455\u20131476 (1999).","journal-title":"Eur. Respir. J."},{"key":"1106_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev.me.40.020189.002243","volume":"40","author":"LG Dobbs","year":"1989","unstructured":"Dobbs, L. G. Pulmonary surfactant. Annu. Rev. Med. 40, 431\u2013446 (1989).","journal-title":"Annu. Rev. Med."},{"key":"1106_CR50","doi-asserted-by":"publisher","first-page":"29872","DOI":"10.1074\/jbc.M113.493957","volume":"288","author":"E Lopez-Rodriguez","year":"2013","unstructured":"Lopez-Rodriguez, E., Cruz, A., Richter, R. P., Taeusch, H. W. & P\u00e9rez-Gil, J. Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state. J. Biol. Chem. 288, 29872\u201329881 (2013).","journal-title":"J. Biol. Chem."},{"key":"1106_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","volume":"291","author":"R Guagliardo","year":"2018","unstructured":"Guagliardo, R., P\u00e9rez-Gil, J., De Smedt, S. & Raemdonck, K. Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins. J. Control. Release 291, 116\u2013126 (2018).","journal-title":"J. Control. Release"},{"key":"1106_CR52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1440-1843.1996.tb00040.x","volume":"1","author":"TE Nicholas","year":"1996","unstructured":"Nicholas, T. E. Pulmonary surfactant: no mere paint on the alveolar wall. Respirology 1, 247\u2013257 (1996).","journal-title":"Respirology"},{"key":"1106_CR53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijpharm.2016.06.029","volume":"514","author":"SC Das","year":"2016","unstructured":"Das, S. C. & Stewart, P. J. The influence of lung surfactant liquid crystalline nanostructures on respiratory drug delivery. Int. J. Pharm. 514, 465\u2013474 (2016).","journal-title":"Int. J. Pharm."},{"key":"1106_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpb.2015.02.014","volume":"95","author":"A Hidalgo","year":"2015","unstructured":"Hidalgo, A., Cruz, A. & P\u00e9rez-Gil, J. Barrier or carrier? Pulmonary surfactant and drug delivery. Eur. J. Pharm. Biopharm. 95, 117\u2013127 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1106_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chemphyslip.2014.09.002","volume":"185","author":"E Parra","year":"2015","unstructured":"Parra, E. & P\u00e9rez-Gil, J. Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chem. Phys. Lipids 185, 153\u2013175 (2015).","journal-title":"Chem. Phys. Lipids"},{"key":"1106_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1084952102000551","volume":"13","author":"TE Weaver","year":"2002","unstructured":"Weaver, T. E., Na, C.-L. & Stahlman, M. Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev. Biol. 13, 263\u2013270 (2002).","journal-title":"Semin Cell Dev. Biol."},{"key":"1106_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.physiol.67.040403.102553","volume":"67","author":"P Dietl","year":"2005","unstructured":"Dietl, P. & Haller, T. Exocytosis of lung surfactant: from the secretory vesicle to the air-liquid interface. Annu. Rev. Physiol. 67, 595\u2013621 (2005).","journal-title":"Annu. Rev. Physiol."},{"key":"1106_CR58","doi-asserted-by":"publisher","first-page":"102244","DOI":"10.1016\/j.cis.2020.102244","volume":"284","author":"F Wang","year":"2020","unstructured":"Wang, F., Liu, J. & Zeng, H. Interactions of particulate matter and pulmonary surfactant: Implications for human health. Adv. Colloid Interface Sci. 284, 102244 (2020).","journal-title":"Adv. Colloid Interface Sci."},{"key":"1106_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ni.3052","volume":"16","author":"M Kopf","year":"2015","unstructured":"Kopf, M., Schneider, C. & Nobs, S. P. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16, 36\u201344 (2015).","journal-title":"Nat. Immunol."},{"key":"1106_CR60","doi-asserted-by":"publisher","first-page":"753940","DOI":"10.3389\/fimmu.2021.753940","volume":"12","author":"F Hou","year":"2021","unstructured":"Hou, F., Xiao, K., Tang, L. & Xie, L. Diversity of macrophages in lung homeostasis and diseases. Front. Immunol. 12, 753940 (2021).","journal-title":"Front. Immunol."},{"key":"1106_CR61","doi-asserted-by":"publisher","first-page":"e20210615","DOI":"10.1084\/jem.20210615","volume":"218","author":"D Pisu","year":"2021","unstructured":"Pisu, D. et al. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J. Exp. Med. 218, e20210615 (2021).","journal-title":"J. Exp. Med."},{"key":"1106_CR62","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","volume":"19","author":"SK Wculek","year":"2021","unstructured":"Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A. & Sancho, D. Metabolism of tissue macrophages in homeostasis and pathology. Cell. Mol. Immunol. 19, 384\u2013408 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"1106_CR63","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","volume":"38","author":"D Hashimoto","year":"2013","unstructured":"Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792\u2013804 (2013).","journal-title":"Immunity"},{"key":"1106_CR64","first-page":"1318","volume":"143","author":"SY Tan","year":"2016","unstructured":"Tan, S. Y. & Krasnow, M. A. Developmental origin of lung macrophage diversity. Development 143, 1318\u20131327 (2016).","journal-title":"Development"},{"key":"1106_CR65","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature13989","volume":"518","author":"E Gomez Perdiguero","year":"2015","unstructured":"Gomez Perdiguero, E. et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547\u2013551 (2015).","journal-title":"Nature"},{"key":"1106_CR66","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.immuni.2016.02.017","volume":"44","author":"L van de Laar","year":"2016","unstructured":"van de Laar, L. et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity 44, 755\u2013768 (2016).","journal-title":"Immunity"},{"key":"1106_CR67","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1164\/rccm.201507-1376OC","volume":"193","author":"AN Desch","year":"2016","unstructured":"Desch, A. N. et al. Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am. J. Respir. Crit. Care Med. 193, 614\u2013626 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1106_CR68","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2613.2012.00833.x","volume":"93","author":"A Alber","year":"2012","unstructured":"Alber, A., Howie, S. E., Wallace, W. A. & Hirani, N. The role of macrophages in healing the wounded lung. Int. J. Exp. Pathol. 93, 243\u2013251 (2012).","journal-title":"Int. J. Exp. Pathol."},{"key":"1106_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri3600","volume":"14","author":"T Hussell","year":"2014","unstructured":"Hussell, T. & Bell, T. J. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81\u201393 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1106_CR70","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.01.033","volume":"45","author":"H Li","year":"2017","unstructured":"Li, H. et al. Isotrifoliol inhibits pro-inflammatory mediators by suppression of TLR\/NF-\u03baB and TLR\/MAPK signaling in LPS-induced RAW264.7 cells. Int. Immunopharmacol. 45, 110\u2013119 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"1106_CR71","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","volume":"39","author":"Y Qiao","year":"2013","unstructured":"Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and toll-like receptor signaling. Immunity 39, 454\u2013469 (2013).","journal-title":"Immunity"},{"key":"1106_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41392-022-00986-0","volume":"7","author":"B Wang","year":"2022","unstructured":"Wang, B. et al. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct. Target. Ther. 7, 143 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR73","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. J. Am. Med. Assoc. 324, 782\u2013793 (2020).","journal-title":"J. Am. Med. Assoc."},{"key":"1106_CR74","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1021\/acs.jproteome.0c00606","volume":"19","author":"T Thomas","year":"2020","unstructured":"Thomas, T. et al. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J. Proteome Res. 19, 4455\u20134469 (2020).","journal-title":"J. Proteome Res."},{"key":"1106_CR75","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.3390\/ijms22105251","volume":"22","author":"M-Y Peng","year":"2021","unstructured":"Peng, M.-Y. et al. Immunological aspects of SARS-CoV-2 infection and the putative beneficial role of vitamin-D. Int. J. Mol. Sci. 22, 5251 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1106_CR76","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna, C., Mengru, H., Lei, W. & Weidong, C. Macrophage M1\/M2 polarization. Eur. J. Pharmacol. 877, 173090 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"1106_CR77","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM-K Tang","year":"2019","unstructured":"Tang, P. M.-K., Nikolic-Paterson, D. J. & Lan, H.-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat. Rev. Nephrol. 15, 144\u2013158 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1106_CR78","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2008","unstructured":"Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453\u2013461 (2008).","journal-title":"Front. Biosci."},{"key":"1106_CR79","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam, A. et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425\u20136440 (2018).","journal-title":"J. Cell. Physiol."},{"key":"1106_CR80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44, 450\u2013462 (2016).","journal-title":"Immunity"},{"key":"1106_CR81","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cmet.2019.01.006","volume":"29","author":"L Du","year":"2019","unstructured":"Du, L. et al. IGF-2 Preprograms maturing macrophages to acquire oxidative phosphorylation-dependent anti-inflammatory properties. Cell Metab. 29, 1363\u20131375 (2019).","journal-title":"Cell Metab."},{"key":"1106_CR82","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.aaj2067","volume":"356","author":"CM Minutti","year":"2017","unstructured":"Minutti, C. M. et al. Local amplifiers of IL-4Ralpha-mediated macrophage activation promote repair in lung and liver. Science 356, 1076\u20131080 (2017).","journal-title":"Science"},{"key":"1106_CR83","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1126\/science.aai8132","volume":"356","author":"L Bosurgi","year":"2017","unstructured":"Bosurgi, L. et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science 356, 1072\u20131076 (2017).","journal-title":"Science"},{"key":"1106_CR84","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson, B. T., Chambers, R. C. & Liu, K. D. Acute respiratory distress syndrome. N. Engl. J. Med. 377, 562\u2013572 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1106_CR85","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George, P. M., Wells, A. U. & Jenkins, R. G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir. Med. 8, 807\u2013815 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1106_CR86","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","volume":"184","author":"D Wendisch","year":"2021","unstructured":"Wendisch, D. et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184, 6243\u20136261 (2021). e6227.","journal-title":"Cell"},{"key":"1106_CR87","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/S0140-6736(15)60402-0","volume":"385","author":"S Shaikh","year":"2015","unstructured":"Shaikh, S., Noshirwani, A., West, N., Perry, S. & Jayne, D. Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy? Lancet 385, S87 (2015).","journal-title":"Lancet"},{"key":"1106_CR88","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1165\/rcmb.2017-0154OC","volume":"58","author":"AL McCubbrey","year":"2018","unstructured":"McCubbrey, A. L. et al. Deletion of c-FLIP from CD11b(hi) macrophages prevents development of bleomycin-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 58, 66\u201378 (2018).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1106_CR89","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2217\/epi-2021-0476","volume":"14","author":"M Shirvaliloo","year":"2022","unstructured":"Shirvaliloo, M. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks. Epigenomics 14, 153\u2013162 (2022).","journal-title":"Epigenomics"},{"key":"1106_CR90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.imbio.2017.10.005","volume":"223","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N. & Bobryshev, Y. V. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. Immunobiology 223, 101\u2013111 (2018).","journal-title":"Immunobiology"},{"key":"1106_CR91","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/all.13369","volume":"73","author":"N Sharma","year":"2018","unstructured":"Sharma, N., Akkoyunlu, M. & Rabin, R. L. Macrophages-common culprit in obesity and asthma. Allergy 73, 1196\u20131205 (2018).","journal-title":"Allergy"},{"key":"1106_CR92","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2020.04.010","volume":"122","author":"L da Costa Loureiro","year":"2020","unstructured":"da Costa Loureiro, L. et al. Pulmonary surfactant phosphatidylcholines induce immunological adaptation of alveolar macrophages. Mol. Immunol. 122, 163\u2013172 (2020).","journal-title":"Mol. Immunol."},{"key":"1106_CR93","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.33549\/physiolres.933672","volume":"66","author":"M Kolomaznik","year":"2017","unstructured":"Kolomaznik, M., Nova, Z. & Calkovska, A. Pulmonary surfactant and bacterial lipopolysaccharide: the interaction and its functional consequences. Physiol. Res. 66, S147\u2013S157 (2017).","journal-title":"Physiol. Res."},{"key":"1106_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03225-9","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen, D. et al. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat. Commun. 9, 873 (2018).","journal-title":"Nat. Commun."},{"key":"1106_CR95","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355\u2013362 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1106_CR96","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"1106_CR97","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/ijms19061801","volume":"19","author":"C Atri","year":"2018","unstructured":"Atri, C., Guerfali, F.Z. & Laouini, D. Role of human macrophage polarization in inflammation during infectious diseases. Int. J. Mol. Sci. 19, 1801 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1106_CR98","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1183\/09031936.00037014","volume":"44","author":"J Petersson","year":"2014","unstructured":"Petersson, J. & Glenny, R. W. Gas exchange and ventilation-perfusion relationships in the lung. Eur. Respir. J. 44, 1023\u20131041 (2014).","journal-title":"Eur. Respir. J."},{"key":"1106_CR99","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/cphy.c150028","volume":"6","author":"CCW Hsia","year":"2016","unstructured":"Hsia, C. C. W., Hyde, D. M. & Weibel, E. R. Lung structure and the intrinsic challenges of gas exchange. Compr. Physiol. 6, 827\u2013895 (2016).","journal-title":"Compr. Physiol."},{"key":"1106_CR100","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00441-016-2545-0","volume":"367","author":"JC Schittny","year":"2017","unstructured":"Schittny, J. C. Development of the lung. Cell Tissue Res. 367, 427\u2013444 (2017).","journal-title":"Cell Tissue Res."},{"key":"1106_CR101","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ymben.2004.03.001","volume":"6","author":"N Zamboni","year":"2004","unstructured":"Zamboni, N., Maaheimo, H., Szyperski, T., Hohmann, H.-P. & Sauer, U. The phosphoenolpyruvate carboxykinase also catalyzes C3 carboxylation at the interface of glycolysis and the TCA cycle of Bacillus subtilis. Metab. Eng. 6, 277\u2013284 (2004).","journal-title":"Metab. Eng."},{"key":"1106_CR102","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/jnc.12812","volume":"131","author":"U Sonnewald","year":"2014","unstructured":"Sonnewald, U. Glutamate synthesis has to be matched by its degradation - where do all the carbons go? J. Neurochem. 131, 399\u2013406 (2014).","journal-title":"J. Neurochem."},{"key":"1106_CR103","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41422-020-00435-z","volume":"30","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Res. 30, 1078\u20131087 (2020).","journal-title":"Cell Res."},{"key":"1106_CR104","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jaci.2021.05.047","volume":"148","author":"W Posch","year":"2021","unstructured":"Posch, W., Lass-Fl\u00f6rl, C. & Wilflingseder, D. SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion. J. Allergy Clin. Immunol. 148, 909 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1106_CR105","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou, X. et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14, 185\u2013192 (2020).","journal-title":"Front. Med."},{"key":"1106_CR106","doi-asserted-by":"publisher","first-page":"107225","DOI":"10.1016\/j.intimp.2020.107225","volume":"90","author":"R Pasrija","year":"2021","unstructured":"Pasrija, R. & Naime, M. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease. Int. Immunopharmacol. 90, 107225 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"1106_CR107","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1289\/ehp.7457","volume":"113","author":"C-C Chang","year":"2005","unstructured":"Chang, C.-C. et al. The induction of vascular endothelial growth factor by ultrafine carbon black contributes to the increase of alveolar-capillary permeability. Environ. Health Perspect. 113, 454\u2013460 (2005).","journal-title":"Environ. Health Perspect."},{"key":"1106_CR108","doi-asserted-by":"publisher","first-page":"102833","DOI":"10.1016\/j.ebiom.2020.102833","volume":"57","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine 57, 102833 (2020).","journal-title":"EBioMedicine"},{"key":"1106_CR109","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41392-021-00851-6","volume":"6","author":"Z Bi","year":"2021","unstructured":"Bi, Z. et al. Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice. Signal Transduct. Target. Ther. 6, 439 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR110","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal, J. et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N. Engl. J. Med. 385, 585\u2013594 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1106_CR111","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/jmv.27588","volume":"94","author":"Y Araf","year":"2022","unstructured":"Araf, Y. et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 94, 1825\u20131832 (2022).","journal-title":"J. Med. Virol."},{"key":"1106_CR112","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct. Target. Ther. 7, 141 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR113","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"1106_CR114","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jmv.27526","volume":"94","author":"S Kumar","year":"2021","unstructured":"Kumar, S., Thambiraja, T. S., Karuppanan, K. & Subramaniam, G. Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J. Med. Virol. 94, 1641\u20131649 (2021).","journal-title":"J. Med. Virol."},{"key":"1106_CR115","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong, Y. et al. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct. Target. Ther. 5, 237 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR116","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","volume":"7","author":"M Li","year":"2022","unstructured":"Li, M. et al. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct. Target. Ther. 7, 146 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR117","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel, D. M. & Gould, S. J. Exosomes. Annu. Rev. Biochem. 88, 487\u2013514 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"1106_CR118","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"1106_CR119","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/eji.202048548","volume":"50","author":"J Ma","year":"2020","unstructured":"Ma, J., Zhang, H., Tang, K. & Huang, B. Tumor-derived microparticles in tumor immunology and immunotherapy. Eur. J. Immunol. 50, 1653\u20131662 (2020).","journal-title":"Eur. J. Immunol."},{"key":"1106_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms2282","volume":"3","author":"K Tang","year":"2012","unstructured":"Tang, K. et al. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat. Commun. 3, 1\u201311 (2012).","journal-title":"Nat. Commun."},{"key":"1106_CR121","doi-asserted-by":"publisher","first-page":"e1309487","DOI":"10.1080\/2162402X.2017.1309487","volume":"6","author":"Y Sun","year":"2017","unstructured":"Sun, Y. et al. Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway. Oncoimmunology 6, e1309487 (2017).","journal-title":"Oncoimmunology"},{"key":"1106_CR122","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586\u2013597 (2016).","journal-title":"Nat. Med."},{"key":"1106_CR123","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1158\/2326-6066.CIR-19-0789","volume":"8","author":"P Xu","year":"2020","unstructured":"Xu, P. et al. Chemotherapeutic tumor microparticles elicit a neutrophil response targeting malignant pleural effusions. Cancer Immunol. Res. 8, 1193\u20131205 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"1106_CR124","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/jev2.12050","volume":"10","author":"F Cocozza","year":"2020","unstructured":"Cocozza, F. et al. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus. J. Extracell. Vesicles 10, e12050 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"1106_CR125","doi-asserted-by":"publisher","first-page":"27141","DOI":"10.1073\/pnas.2014352117","volume":"117","author":"L Rao","year":"2020","unstructured":"Rao, L. et al. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc. Natl Acad. Sci. USA 117, 27141\u201327147 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1106_CR126","doi-asserted-by":"publisher","first-page":"e1118599","DOI":"10.1080\/2162402X.2015.1118599","volume":"5","author":"R Ma","year":"2016","unstructured":"Ma, R. et al. Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression. Oncoimmunology 5, e1118599 (2016).","journal-title":"Oncoimmunology"},{"key":"1106_CR127","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2326-6066.CIR-14-0177","volume":"3","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS\/STING signaling. Cancer Immunol. Res. 3, 196\u2013205 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"1106_CR128","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501\u2013521 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1106_CR129","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Bai, X.-C. & Chen, Z. J. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity 53, 43\u201353 (2020).","journal-title":"Immunity"},{"key":"1106_CR130","doi-asserted-by":"publisher","first-page":"eaav9166","DOI":"10.1126\/scitranslmed.aav9166","volume":"12","author":"LE Surface","year":"2020","unstructured":"Surface, L. E. et al. ATRAID regulates the action of nitrogen-containing bisphosphonates on bone. Sci. Transl. Med. 12, eaav9166 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1106_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-015-3334-4","volume":"27","author":"P Eiken","year":"2016","unstructured":"Eiken, P. & Vestergaard, P. Treatment of osteoporosis after alendronate or risedronate. Osteoporosis Int. 27, 1\u201312 (2016).","journal-title":"Osteoporosis Int."},{"key":"1106_CR132","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","volume":"74","author":"T Asselah","year":"2021","unstructured":"Asselah, T., Durantel, D., Pasmant, E., Lau, G. & Schinazi, R. F. COVID-19: discovery, diagnostics and drug development. J. Hepatol. 74, 168\u2013184 (2021).","journal-title":"J. Hepatol."},{"key":"1106_CR133","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/all.14595","volume":"76","author":"E Andreakos","year":"2021","unstructured":"Andreakos, E., Papadaki, M. & Serhan, C. N. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19. Allergy 76, 626\u2013628 (2021).","journal-title":"Allergy"},{"key":"1106_CR134","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41392-022-00977-1","volume":"7","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages. Signal Transduct. Target. Ther. 7, 116 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1106_CR135","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbrc.2013.10.115","volume":"441","author":"A Laskar","year":"2013","unstructured":"Laskar, A., Eilertsen, J., Li, W. & Yuan, X. M. SPION primes THP1 derived M2 macrophages towards M1-like macrophages. Biochem. Biophys. Res. Commun. 441, 737\u2013742 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1106_CR136","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1016\/S2666-5247(21)00068-9","volume":"2","author":"S Jangra","year":"2021","unstructured":"Jangra, S. et al. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe 2, e283\u2013e284 (2021).","journal-title":"Lancet Microbe"},{"key":"1106_CR137","doi-asserted-by":"publisher","first-page":"n296","DOI":"10.1136\/bmj.n296","volume":"372","author":"E Mahase","year":"2021","unstructured":"Mahase, E. Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant. BMJ 372, n296 (2021).","journal-title":"BMJ"},{"key":"1106_CR138","doi-asserted-by":"publisher","unstructured":"Lu, L. et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciab1041 (2021).","DOI":"10.1093\/cid\/ciab1041"},{"key":"1106_CR139","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","volume":"54","author":"Q Fernandes","year":"2022","unstructured":"Fernandes, Q. et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med. 54, 524\u2013540 (2022).","journal-title":"Ann. Med."},{"key":"1106_CR140","doi-asserted-by":"publisher","first-page":"e0207721","DOI":"10.1128\/jvi.02077-21","volume":"96","author":"C Jung","year":"2022","unstructured":"Jung, C. et al. Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning? J. Virol. 96, e0207721 (2022).","journal-title":"J. Virol."},{"key":"1106_CR141","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","volume":"185","author":"WF Garcia-Beltran","year":"2022","unstructured":"Garcia-Beltran, W. F. et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell 185, 457\u2013466 (2022).","journal-title":"Cell"},{"key":"1106_CR142","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","volume":"603","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 603, 687\u2013692 (2022).","journal-title":"Nature"},{"key":"1106_CR143","doi-asserted-by":"publisher","first-page":"e123158","DOI":"10.1172\/jci.insight.123158","volume":"4","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019).","journal-title":"JCI Insight"},{"key":"1106_CR144","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/infdis\/jit504","volume":"209","author":"J Zhou","year":"2014","unstructured":"Zhou, J. et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. 209, 1331\u20131342 (2014).","journal-title":"J. Infect. Dis."},{"key":"1106_CR145","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"1106_CR146","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01106-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:05:38Z","timestamp":1669230338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01106-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":146,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01106-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}